{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:13:18Z","timestamp":1744258398466,"version":"3.40.4"},"reference-count":327,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121907","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:05:53Z","timestamp":1688137553000},"page":"121907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness"],"prefix":"10.1016","volume":"328","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1744-4578","authenticated-orcid":false,"given":"Somayeh","family":"Yazdanparast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-3095","authenticated-orcid":false,"given":"Mehdi","family":"Bakhtiyaridovvombaygi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-7245","authenticated-orcid":false,"given":"Fatemeh","family":"Mikanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-3178","authenticated-orcid":false,"given":"Reza","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8829-4258","authenticated-orcid":false,"given":"Mohammad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8236-5980","authenticated-orcid":false,"given":"Mohammad Reza","family":"Mansoorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-4980","authenticated-orcid":false,"given":"Mozhgan","family":"Mansoorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-6489","authenticated-orcid":false,"given":"Hamid","family":"Chegni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-2747","authenticated-orcid":false,"given":"Jalil","family":"Moshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-585X","authenticated-orcid":false,"given":"Ahmad","family":"Gharehbaghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","article-title":"Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence","volume":"14","author":"Rahman","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40249-020-00691-6","article-title":"Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2","volume":"9","author":"Zhang","year":"2020","journal-title":"Infect. Dis. Poverty"},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/14787210.2021.1863146","article-title":"An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies","volume":"19","author":"Tsang","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0020","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0025","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00705-021-05070-6","article-title":"Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection","volume":"166","author":"Mohammad","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.lfs.2023.121907_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109128","article-title":"Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination","volume":"111","author":"Delshad","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0035","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/ijms22052636","article-title":"The role of immunogenetics in COVID-19","volume":"22","author":"Pojero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0045","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/20009666.2021.1974665","article-title":"COVID-19 reinfection: the role of natural immunity, vaccines, and variants","volume":"11","author":"Sciscent","year":"2021","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0055","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/JVI.06540-11","article-title":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavi","volume":"86","author":"Woo","year":"2012","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)","volume":"35","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12931-020-01581-z","article-title":"SARS coronavirus 2: from genome to infectome","volume":"21","author":"Rastogi","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2023.121907_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-0-387-33012-9_29","article-title":"Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly","volume":"581","author":"Masters","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cells10040821","article-title":"Role of structural and non-structural proteins and therapeutic targets of SARS-COV-2 for COVID-19","volume":"10","author":"Yadav","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-COV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"year":"2022","series-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)","author":"Cascella","key":"10.1016\/j.lfs.2023.121907_bb0105"},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.lfs.2023.121907_bb0115","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-I-converting enzyme and its relatives","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.lfs.2023.121907_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, much more than just a receptor for SARS-COV-2","volume":"10","author":"Samavati","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biologics1010002","article-title":"Overview of COVID-19 disease: virology, epidemiology, prevention diagnosis, treatment, and vaccines","volume":"1","author":"Salahshoori","year":"2021","journal-title":"Biologics"},{"issue":"10223","key":"10.1016\/j.lfs.2023.121907_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2023.121907_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajem.2022.01.028","article-title":"Clinical update on COVID-19 for the emergency clinician: presentation and evaluation","volume":"54","author":"Long","year":"2022","journal-title":"Am. J. Emerg. Med."},{"issue":"34","key":"10.1016\/j.lfs.2023.121907_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109229118","article-title":"Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"118","author":"Sah","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121907_bb0150","first-page":"57","article-title":"Changes in symptoms experienced by SARS-CoV-2-infected individuals-from the first wave to the omicron variant","author":"Schulze","year":"2022","journal-title":"Front. Virol."},{"key":"10.1016\/j.lfs.2023.121907_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2020.11.021","article-title":"COVID19-clinical presentation and therapeutic considerations","volume":"538","author":"Kenny","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102536","article-title":"ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia","volume":"19","author":"Rivellese","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"9371","key":"10.1016\/j.lfs.2023.121907_bb0165","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet (Lond. Engl.)"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0170","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1053\/j.gastro.2020.05.036","article-title":"Are gastrointestinal symptoms specific for coronavirus 2019 infection? A prospective case-control study from the United States","volume":"159","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121907_bb0175","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0714-2020","article-title":"COVID-19 gastrointestinal manifestations: a systematic review","volume":"53","author":"Silva","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.lfs.2023.121907_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19 - a systematic review","volume":"254","author":"Kermali","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.121907_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sleep.2020.04.006","article-title":"Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients?","volume":"70","author":"Zambrelli","year":"2020","journal-title":"Sleep Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0190","first-page":"773","article-title":"Neurological manifestations of coronavirus disease 2019: exploring past to understand present","volume":"42","author":"Desai","year":"2021","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0195","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.medmal.2020.04.006","article-title":"Features of anosmia in COVID-19","volume":"50","author":"Klopfenstein","year":"2020","journal-title":"M\u00e9d. Mal. Infect."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0205","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3174\/ajnr.A6650","article-title":"COVID-19 is an independent risk factor for acute ischemic stroke","volume":"41","author":"Belani","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2214\/AJR.20.23847","article-title":"Association of coronavirus disease (COVID-19) with large vessel occlusion strokes: a case-control study","volume":"216","author":"Kihira","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb0215","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1161\/STROKEAHA.120.031265","article-title":"Cerebrovascular complications of COVID-19","volume":"51","author":"Katz","year":"2020","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.lfs.2023.121907_bb0220","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2023.121907_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0230","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3174\/ajnr.A6595","article-title":"Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection","volume":"41","author":"Franceschi","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet. Neurol."},{"issue":"10235","key":"10.1016\/j.lfs.2023.121907_bb0240","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0140-6736(20)30912-0","article-title":"Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes","volume":"395","author":"Doyen","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb0245","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/ehjci\/jeaa178","article-title":"Global evaluation of echocardiography in patients with COVID-19","volume":"21","author":"Dweck","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2023.121907_bb0250","article-title":"Myocardial fibrosis after COVID-19 infection and severe sinus arrest episodes in an asymptomatic patient with mild sleep apnea syndrome: a case report and review of the literature","volume":"32","author":"Lampropoulos","year":"2021","journal-title":"Respir. Med. Case Rep."},{"issue":"16","key":"10.1016\/j.lfs.2023.121907_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017756","article-title":"Coronavirus 2019 disease (COVID-19), systemic inflammation, and cardiovascular disease","volume":"9","author":"Inciardi","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2023.121907_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajem.2020.09.065","article-title":"Thrombotic complications of COVID-19","volume":"39","author":"Avila","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0265","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0270","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0275","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jvs.2020.04.483","article-title":"Acute limb ischemia in patients with COVID-19 pneumonia","volume":"72","author":"Bellosta","year":"2020","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.lfs.2023.121907_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.815743","article-title":"Case report: rowell syndrome\u2013like flare of cutaneous lupus erythematosus following COVID-19 infection","volume":"9","author":"Drenovska","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13256-020-02582-8","article-title":"Systemic lupus erythematosus manifestation following COVID-19: a case report","volume":"15","author":"Zamani","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.lfs.2023.121907_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.21037\/acr-21-55","article-title":"New onset systemic lupus erythematosus after COVID-19 infection: a case report","volume":"6","author":"Ramachandran","year":"2022","journal-title":"AME Case Rep."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"13","key":"10.1016\/j.lfs.2023.121907_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22137017","article-title":"Innate immune response to SARS-COV-2 infection: from cells to soluble mediators","volume":"22","author":"Ricci","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb0310","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/iub.2379","article-title":"SARS-CoV-2 multifaceted interaction with the human host. Part II: innate immunity response, immunopathology, and epigenetics","volume":"72","author":"Beacon","year":"2020","journal-title":"IUBMB Life"},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/v13102060","article-title":"An update on innate immune responses during SARS-COV-2 infection","volume":"13","author":"Zhang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2023.121907_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.741502","article-title":"Defining the innate immune responses for SARS-CoV-2-human macrophage interactions","volume":"12","author":"Abdelmoaty","year":"2021","journal-title":"Front. Immunol."},{"issue":"67","key":"10.1016\/j.lfs.2023.121907_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01229","article-title":"Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in COVID-19: key therapeutic targets?","volume":"11","author":"Sallenave","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0335","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0340","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0345","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2023.121907_bb0350","series-title":"SARS-CoV-2 Infection: The Viral Arms Race and Pattern-recognition Receptors","first-page":"34","volume":"4 (2)","author":"Liu","year":"2022"},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0355","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0360","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41419-020-03127-z","article-title":"Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0365","first-page":"392","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Natl. Publ. Gr."},{"issue":"4S","key":"10.1016\/j.lfs.2023.121907_bb0370","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.ijtb.2020.07.034","article-title":"Benefits and limitations of serological assays in COVID-19 infection","volume":"67","author":"Sidiq","year":"2020","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.lfs.2023.121907_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580641","article-title":"COVID-19: perspectives on innate immune evasion","volume":"11","author":"Taefehshokr","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0380","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41590-017-0012-z","article-title":"Diversification of human plasmacytoid predendritic cells in response to a single stimulus article","volume":"19","author":"Alculumbre","year":"2018","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0385","first-page":"167","article-title":"The correlation between the percent of CD3- CD56+ cells and NK precursor function","volume":"5","author":"Gharehbaghian","year":"2006","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121907_bb0390","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-1759(01)00534-8","article-title":"Quantitation of natural killer cell precursors in man","volume":"260","author":"Gharehbaghian","year":"2002","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0395","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.672523","article-title":"Regulation and function of ILC3s in pulmonary infections","volume":"12","author":"Hoffmann","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb0405","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1128\/JVI.02943-12","article-title":"Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection","volume":"87","author":"Ivanov","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2023.121907_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109388","article-title":"IL-18\/IL-18BP and IL-22\/IL-22BP: two interrelated couples with therapeutic potential","volume":"63","author":"M\u00fchl","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2023.121907_bb0415","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/JIR.S267280","article-title":"Role of IFN and complements system: innate immunity in SARS-COV-2","volume":"13","author":"Shibabaw","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.lfs.2023.121907_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840137","article-title":"How the innate immune system of the blood contributes to systemic pathology in COVID-19-induced ARDS and provides potential targets for treatment","volume":"13","author":"Nilsson","year":"2022","journal-title":"Front. Immunol."},{"issue":"2 SUPPL. 2","key":"10.1016\/j.lfs.2023.121907_bb0425","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.lfs.2023.121907_bb0430","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0463.2009.02451.x","article-title":"Co-ordinating innate and adaptive immunity to viral infection: mobility is the key","volume":"117","author":"Christensen","year":"2009","journal-title":"APMIS."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0435","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","article-title":"The germinal centre B cell response to SARS-CoV-2","volume":"22","author":"Laidlaw","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0440","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cca.2020.09.015","article-title":"Update on serologic testing in COVID\u201319","volume":"510","author":"Krajewski","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0445","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CPM.0000000000000374","article-title":"Laboratory diagnosis of COVID-19","volume":"27","author":"Asgharzadeh","year":"2020","journal-title":"Clin. Pulm. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0450","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00763-2020","article-title":"Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset","volume":"56","author":"Lou","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41415-020-2228-9","article-title":"Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2","volume":"229","author":"Denning","year":"2020","journal-title":"Br. Dent. J."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb0460","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1051\/medsci\/2021154","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus","volume":"37","author":"Sterlin","year":"2021","journal-title":"Medecine\/Sciences"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0465","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jmv.26330","article-title":"Analysis of the application value of serum antibody detection for staging of COVID-19 infection","volume":"93","author":"Zheng","year":"2021","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0470","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","article-title":"Dissecting antibody-mediated protection against SARS-CoV-2","volume":"20","author":"Zohar","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0475","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2021.06.001","article-title":"Analysis of the molecular mechanism of SARS-CoV-2 antibodies","volume":"566","author":"Jin","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/Spectrum.01352-21","article-title":"Structural basis of a human neutralizing antibody specific to the SARS-CoV-2 spike protein receptor-binding domain","volume":"9","author":"Yang","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0485","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/jiab540","article-title":"Anti-severe acute respiratory syndrome coronavirus 2 hyperimmune immunoglobulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins","volume":"225","author":"Diez","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0490","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.gim.2022.04.005","article-title":"High-affinity Fc\u03b3RIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19","volume":"24","author":"Vietzen","year":"2020","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0247640","article-title":"Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma","volume":"16","author":"Tso","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0500","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-021-00759-1","article-title":"Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2023.121907_bb0505","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fimmu.2019.00332","article-title":"Antibody dependent cellular phagocytosis in antiviral immune responses","volume":"10","author":"Tay","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01066","article-title":"Phagocytosis: our current understanding of a universal biological process","volume":"11","author":"Uribe-Querol","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb0515","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to combat viral infections: development strategies and progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2023.121907_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.640093","article-title":"Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies","volume":"12","author":"Ricke","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-03273-0","article-title":"The potential of COVID-19 patients\u2019 sera to cause antibody-dependent enhancement of infection and IL-6 production","volume":"11","author":"Shimizu","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0530","first-page":"1","article-title":"Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires Fc\u03b3RIIB and virus-antibody complex with bivalent interaction","volume":"5","author":"Wang","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2023.121907_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20587384211050199","article-title":"A review: antibody-dependent enhancement in COVID-19: the not so friendly side of antibodies","volume":"35","author":"S\u00e1nchez-Zuno","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121907_bb0540","doi-asserted-by":"crossref","unstructured":"Ajmeriya S, Kumar A, Karmakar S, Rana S, Singh H. Neutralizing antibodies and antibody-dependent enhancement in COVID-19: a perspective. J. Indian Inst. Sci. 102 (2) (3020) 671\u201387.","DOI":"10.1007\/s41745-021-00268-8"},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0545","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0550","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/acscentsci.0c01537","article-title":"CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2","volume":"7","author":"Amraei","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.lfs.2023.121907_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24377-1","article-title":"SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells","volume":"12","author":"Jung","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb0565","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0570","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/eji.200939722","article-title":"Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity","volume":"39","author":"Sallusto","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0580","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cells10061550","article-title":"The role of th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.13131","article-title":"COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: potential targets and challenges","volume":"95","author":"Pourgholaminejad","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2021.624483","article-title":"T-helper cell subset response is a determining factor in COVID-19 progression","volume":"11","author":"Gil-Etayo","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2023.121907_bb0595","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T cell response to respiratory virus infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0600","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"19","key":"10.1016\/j.lfs.2023.121907_bb0605","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","article-title":"The HLA system: genetics, immunology, clinical testing, and clinical implications","volume":"48","author":"Choo","year":"2007","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1071\/MA21020","article-title":"HLA and immunodominance in viral infection: T-cell responses in protection and immunopathogenesis","volume":"42","author":"Imrie","year":"2021","journal-title":"Microbiol. Aust."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0620","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/imr.12897","article-title":"The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity","volume":"296","author":"Ovsyannikova","year":"2020","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0625","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tan.13941","article-title":"Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)","volume":"96","author":"Wang","year":"2020","journal-title":"Hla."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0630","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42003-022-03893-w","article-title":"HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2","volume":"5","author":"Olafsdottir","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2023.121907_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.622176","article-title":"Genetics insight for COVID-19 susceptibility and severity: a review","volume":"12","author":"Fricke-Galindo","year":"2021","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.lfs.2023.121907_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155205","article-title":"Hla-b*44 and c*01 prevalence correlates with COVID-19 spreading across Italy","volume":"21","author":"Correale","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.lfs.2023.121907_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00510-20","article-title":"Human leukocyte antigen susceptibility map for SARS-CoV-2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0650","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/iid3.358","article-title":"Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis","volume":"8","author":"Tomita","year":"2020","journal-title":"Immun. Inflamm. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0655","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cels.2020.08.011","article-title":"Estimating the binding of Sars-CoV-2 peptides to HLA class I in human subpopulations using artificial neural networks","volume":"11","author":"La Porta","year":"2020","journal-title":"Cell Syst."},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb0660","first-page":"2433","article-title":"The potential association of human leukocyte antigen (Hla)-a and-b with COVID-19 mortality: a neglected risk factor","volume":"49","author":"Saadati","year":"2020","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.lfs.2023.121907_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.605688","article-title":"Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. The Sardinian experience","volume":"11","author":"Littera","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0670","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41431-022-01070-5","article-title":"Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses","volume":"30","author":"Zhang","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb0675","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/v12111333","article-title":"Population difference in allele frequency of hla-c*05 and its correlation with COVID-19 mortality","volume":"12","author":"Sakuraba","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0680","first-page":"96","article-title":"HLA genetic polymorphisms and prognosis of patients with COVID-19","volume":"45","author":"Lorente","year":"2021","journal-title":"Med. Int."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02515-5","article-title":"Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of COVID-19","volume":"18","author":"Pisanti","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41421-020-00231-4","article-title":"Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb0695","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116730119","article-title":"Specialized interferon action in COVID-19","volume":"119","author":"Galbraith","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0700","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00018-020-03671-z","article-title":"Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway","volume":"78","author":"Rojas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0705","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cyto.2015.07.019","article-title":"Cut, copy, move, delete: the study of human interferon genes reveal multiple mechanisms underlying their evolution in amniotes","volume":"76","author":"Krause","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2023.121907_bb0710","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.lfs.2023.121907_bb0715","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1074\/jbc.R117.777102","article-title":"Contribution of type III interferons to antiviral immunity: location, location, location","volume":"292","author":"Kotenko","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0720","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2023.121907_bb0725","first-page":"43","article-title":"Association of cytokine and chemokine gene polymorphisms with severe acute respiratory syndrome","volume":"15","author":"Lau","year":"2009","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.lfs.2023.121907_bb0730","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-6-82","article-title":"The interferon gamma gene polymorphism +874 A\/T is associated with severe acute respiratory syndrome","volume":"6","author":"Chong","year":"2006","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb0735","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1002\/jmv.27849","article-title":"Individual genetic variability mainly of proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease","volume":"94","author":"Vakil","year":"2022","journal-title":"J. Med. Virol."},{"issue":"6515","key":"10.1016\/j.lfs.2023.121907_bb0740","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.121907_bb0745","doi-asserted-by":"crossref","unstructured":"Rugwizangoga B, Andersson ME, Kabayiza J-C, Nilsson MS, \u00c1rmannsd\u00f3ttir B, Aurelius J, Nilsson S, Hellstrand K, Lindh M, Martner A. IFNL4 genotypes predict clearance of RNA viruses in Rwandan children with upper respiratory tract infections. Front. Cell. Infect. Microbiol. 9 (219) 340.","DOI":"10.3389\/fcimb.2019.00340"},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0750","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3390\/jcm9103315","article-title":"SARS-CoV-2 viral load, IFN\u03bb polymorphisms and the course of COVID-19: an observational study","volume":"9","author":"Amodio","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0755","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12985-021-01692-z","article-title":"The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients","volume":"18","author":"Rahimi","year":"2021","journal-title":"Virol. J."},{"issue":"7848","key":"10.1016\/j.lfs.2023.121907_bb0760","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.121907_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949413","article-title":"IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19","volume":"13","author":"Fricke-Galindo","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0770","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2020.05.016","article-title":"A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection","volume":"181","author":"Casanova","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.121907_bb0775","doi-asserted-by":"crossref","unstructured":"Minashkin MM, Grigortsevich NY, Kamaeva AS, Barzanova V V, Traspov AA, Godkov MA, et al. The role of genetic factors in the development of acute respiratory viral infection COVID-19: predicting severe course and outcomes. Biomedicines. 10 (3) (222) 549.","DOI":"10.3390\/biomedicines10030549"},{"key":"10.1016\/j.lfs.2023.121907_bb0780","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.acc.2021.07.002","article-title":"Host polymorphisms and COVID-19 infection","volume":"107","author":"Delanghe","year":"2022","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb0785","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/pathogens11020195","article-title":"The association between TNF-\u03b1, IL-6, and vitamin D levels and COVID-19 severity and mortality: a systematic review and meta-analysis","volume":"11","author":"Halim","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-022-00274-0","article-title":"The role of tumor necrosis factor alpha\u2212 308A> G polymorphism on the clinical states of SARS-CoV-2 infection","volume":"23","author":"Sotomayor-Lugo","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24400","article-title":"Association of tumor necrosis factor alpha -308 single nucleotide polymorphism with SARS CoV-2 infection in an Iraqi Kurdish population","volume":"36","author":"Ali","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0800","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/cbin.11807","article-title":"Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID-19 risk and severity in an Iranian population","volume":"46","author":"Rokni","year":"2022","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0805","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/08820139.2020.1851709","article-title":"Association of TNF-\u03b1 G-308 a promoter polymorphism with the course and outcome of COVID-19 patients","volume":"51","author":"Saleh","year":"2022","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.lfs.2023.121907_bb0810","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.intimp.2018.11.015","article-title":"Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer","volume":"66","author":"Du","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0815","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1399-0039.1998.tb03002.x","article-title":"Polymorphism of the 5\u2032-flanking region of the human tumor necrosis factor (TNF)-\u03b1 gene in Japanese","volume":"51","author":"Higuchi","year":"1998","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0820","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jlb.66.4.562","article-title":"Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease","volume":"66","author":"Abraham","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"16","key":"10.1016\/j.lfs.2023.121907_bb0825","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.3390\/ijms22168423","article-title":"Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality","volume":"22","author":"Palacios","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0830","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/infdis\/jiac101","article-title":"TNFRSF1B and TNF variants are associated with differences in levels of soluble tumor necrosis factor receptors in patients with severe COVID-19","volume":"226","author":"Fricke-Galindo","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"5537","key":"10.1016\/j.lfs.2023.121907_bb0835","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","article-title":"BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF","volume":"293","author":"Thompson","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0840","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/genes12060881","article-title":"The TNFRSF13C H159Y variant is associated with severe COVID-19: a retrospective study of 500 patients from southern Italy","volume":"12","author":"Russo","year":"2021","journal-title":"Genes (Basel)"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0845","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2021.702507","article-title":"IL-10 and IL-12 (P70) levels predict the risk of COVID-19 progression in hypertensive patients: insights from the brace-corona trial","volume":"8","author":"Moll-Bernardes","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-20087-w","article-title":"Upregulation of interleukin-19 in saliva of patients with COVID-19","volume":"12","author":"Saheb Sharif-Askari","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121907_bb0860","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.808797","article-title":"The role of interleukin-8 in lung inflammation and injury: implications for the management of COVID-19 and hyperinflammatory acute respiratory distress syndrome","volume":"12","author":"Cesta","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0002183","article-title":"IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese","volume":"3","author":"Tang","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0870","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Zulvikar Syambani Ulhaq GVS","year":"2020","journal-title":"Med. Mal. Infect."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0875","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb0880","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0885","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0890","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/cbin.11807","article-title":"Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID-19 risk and severity in an Iranian population","volume":"46","author":"Rokni","year":"2022","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2023.121907_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155662","article-title":"Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients","volume":"148","author":"Smieszek","year":"2021","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0900","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-022-00923-1","article-title":"A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19","volume":"7","author":"Gong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb0905","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4167\/jbv.2021.51.3.089","article-title":"Roles of interleukin-17 and th17 responses in COVID-19","volume":"51","author":"Kang","year":"2021","journal-title":"J. Bacteriol. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb0910","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0915","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.121907_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111980","article-title":"Interleukin-17A (IL-17A): a silent amplifier of COVID-19","volume":"142","author":"Maione","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102572","article-title":"Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms","volume":"19","author":"Raucci","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0930","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1002\/jmv.27127","article-title":"Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries","volume":"93","author":"Batur","year":"2021","journal-title":"Med. Virol."},{"key":"10.1016\/j.lfs.2023.121907_bb0935","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4761631","article-title":"Association of interleukin-17F polymorphism and mortality predictors with the risk of COVID-19","volume":"2022","author":"El-Desoky","year":"2022","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0940","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","article-title":"COVID-19: a case for inhibiting IL-17?","volume":"20","author":"Pacha","year":"2020","journal-title":"Nat. Rev. Immunol. (Internet)"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur. J. Immunogenet."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0950","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40246-023-00468-6","article-title":"Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants","volume":"17","author":"Abbood","year":"2023","journal-title":"Hum. Genomics"},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb0955","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/vim.2018.0120","article-title":"Association of single nucleotide polymorphisms in TNFA and IL10 genes with disease severity in influenza A\/H1N1pdm09 virus infections: a study from Western India","volume":"31","author":"Choudhary","year":"2018","journal-title":"Viral Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb0960","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/vim.2021.0022","article-title":"Lack of effects of the genetic polymorphisms of interleukin-10 in clinical outcomes of COVID-19","volume":"34","author":"Avenda\u00f1o-F\u00e9lix","year":"2021","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0965","doi-asserted-by":"crossref","DOI":"10.1186\/s43042-022-00344-3","article-title":"Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19","volume":"23","author":"Rizvi","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"24","key":"10.1016\/j.lfs.2023.121907_bb0970","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1074\/jbc.M112.438515","article-title":"Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry","volume":"288","author":"Anafu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb0975","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/v11060548","article-title":"IFITM3 clusters on virus containing endosomes and lysosomes early in the influenza a infection of human airway epithelial cells","volume":"11","author":"Kummer","year":"2019","journal-title":"Viruses"},{"issue":"7395","key":"10.1016\/j.lfs.2023.121907_bb0980","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0985","first-page":"19","article-title":"IFITM3: how genetics influence influenza infection demographically","volume":"42","author":"Wellington","year":"2019","journal-title":"Biom. J."},{"key":"10.1016\/j.lfs.2023.121907_bb0990","article-title":"Association between rs12252 and influenza susceptibility and severity: an updated meta-analysis","volume":"147","author":"Chen","year":"2018","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb0995","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","article-title":"Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019","volume":"222","author":"Zhang","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb1000","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.ygeno.2021.04.002","article-title":"Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality","volume":"113","author":"Alghamdi","year":"2021","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/infdis\/jiaa630","article-title":"Minor allele of interferon-induced transmembrane protein 3 polymorphism (rs12252) is covered against severe acute respiratory syndrome coronavirus 2 infection and mortality: a worldwide epidemiological investigation","volume":"223","author":"Pati","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s43162-022-00141-9","article-title":"Association of interferon gamma inducible protein-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-1 alpha, interleukin-6, and rs12252 single nucleotide polymorphism of interferon-induced transmembrane protein-3 gene with the sever","volume":"34","author":"Mulla","year":"2022","journal-title":"Egypt. J. Intern. Med."},{"key":"10.1016\/j.lfs.2023.121907_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155957","article-title":"Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality","volume":"157","author":"Ahmadi","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2023.121907_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155492","article-title":"The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19","volume":"142","author":"Sch\u00f6nfelder","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2023.121907_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153647","article-title":"Host factors: implications in immunopathogenesis of COVID-19","volume":"228","author":"Jafarpour","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/genes12010042","article-title":"Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 (IFITM3) gene at the population-level","volume":"12","author":"Kim","year":"2020","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13273-021-00123-y","article-title":"The first association study of single-nucleotide polymorphisms (SNPs) of the IFITM1 gene with influenza H1N1 2009 pandemic virus infection","volume":"17","author":"Kim","year":"2021","journal-title":"Mol. Cell. Toxicol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1040","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.110","article-title":"Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases","volume":"47","author":"Choi","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"41","key":"10.1016\/j.lfs.2023.121907_bb1045","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1074\/jbc.RA118.004747","article-title":"A human cellular noncoding RNA activates the antiviral protein 2\u2032-5\u2032-oligoadenylate synthetase 1","volume":"293","author":"Calderon","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"6567","key":"10.1016\/j.lfs.2023.121907_bb1050","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj3624","article-title":"A prenylated dsRNA sensor protects against severe COVID-19","volume":"374","author":"Wickenhagen","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb1055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026309118","article-title":"A genomic region associated with protection against severe COVID-19 is inherited from Neandertals","volume":"118","author":"Zeberg","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lfs.2023.121907_bb1060","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41591-021-01281-1","article-title":"A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity","volume":"27","author":"Zhou","year":"2021","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41588-022-01113-z","article-title":"Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries","volume":"54","author":"Banday","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2023.121907_bb1070","series-title":"Expression and Function of Chemokines During Viral Infections: From Molecular Mechanisms to In Vivo Function","first-page":"331","volume":"74","author":"Melchjorsen","year":"2003"},{"key":"10.1016\/j.lfs.2023.121907_bb1075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"20","key":"10.1016\/j.lfs.2023.121907_bb1080","first-page":"19","article-title":"Case report pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"2600","author":"Xu","year":"2020","journal-title":"Lancet Respir."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine receptors: multifaceted therapeutic targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"257","key":"10.1016\/j.lfs.2023.121907_bb1090","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions","volume":"15","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2023.121907_bb1100","series-title":"Lung Under Attack by COVID-19-induced Cytokine Storm: Pathogenic Mechanisms and Therapeutic Implications","volume":"14","author":"Pelaia","year":"2020"},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb1105","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/08820139.2022.2088383","article-title":"Effect of chemokine gene variants on COVID-19 disease severity","volume":"51","author":"Dogan","year":"2022","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.lfs.2023.121907_bb1110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832394","article-title":"The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections","volume":"13","author":"Hsu","year":"2022","journal-title":"Front. Immunol."},{"year":"2020","series-title":"The CCR5-delta32 Variant Might Explain Part of the Association Between COVID-19 and the Chemokine-receptor Gene Cluster","author":"G\u00f3mez","key":"10.1016\/j.lfs.2023.121907_bb1115"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/infdis\/jiaa349","article-title":"Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients","volume":"222","author":"Tong","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1125","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1038\/s41467-022-34638-2","article-title":"Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples","volume":"13","author":"Liechti","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb1130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","article-title":"Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome","volume":"202","author":"Hue","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41392-020-0211-1","article-title":"Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9414","key":"10.1016\/j.lfs.2023.121907_bb1140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(04)15837-6","article-title":"Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency","volume":"363","author":"Gharehbaghian","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12684","article-title":"Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology","volume":"150","author":"B\u00e9ziat","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2023.121907_bb1155","article-title":"Association of KIR gene polymorphisms with COVID-19 disease","volume":"234","author":"Hajeer","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2022.845474","article-title":"Individualized constellation of killer cell immunoglobulin-like receptors and cognate HLA class I ligands that controls natural killer cell antiviral immunity predisposes COVID-19","volume":"13","author":"Maruthamuthu","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1165","first-page":"101","article-title":"The association between proportion HLA-BW4 or HLA-BW6 may causes immunity failure in COVID-19","volume":"21","author":"Chegni","year":"2022","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb1170","first-page":"1","article-title":"The KIR2DL2\/HLA-C1C1 gene pairing is associated with an increased risk of SARS-CoV-2 infection","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb1175","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41436-020-01077-7","article-title":"Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19","volume":"23","author":"Vietzen","year":"2021","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1180","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28404","article-title":"The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19","volume":"95","author":"Vietzen","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cti2.1359","article-title":"Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease","volume":"11","author":"Jaiswal","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb1195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2567.2007.02651.x","article-title":"Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells","volume":"122","author":"Liu","year":"2007","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-019-0227-2","article-title":"Toll-like receptors activation, signaling, and targeting: an overview","volume":"43","author":"El-Zayat","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmv.26387","article-title":"Targeting human TLRs to combat COVID-19: a solution?","volume":"93","author":"Patra","year":"2021","journal-title":"J. Med. Virol."},{"issue":"4\u20135","key":"10.1016\/j.lfs.2023.121907_bb1215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","article-title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes","volume":"22","author":"Moreno-Eutimio","year":"2020","journal-title":"Microbes Infect."},{"issue":"38","key":"10.1016\/j.lfs.2023.121907_bb1220","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb1225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000562","article-title":"Evolutionary dynamics of human toll-like receptors and their different contributions to host defense","volume":"5","author":"Barreiro","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.lfs.2023.121907_bb1230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb1235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"Van Der Made","year":"2020","journal-title":"JAMA \u2013 J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"MBio"},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb1245","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1534\/g3.117.041434","article-title":"Allelic variation in the toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice","volume":"7","author":"Gralinski","year":"2017","journal-title":"G3 Genes, Genomes, Genet."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1250","first-page":"161","article-title":"Complement activation during critical illness: current findings and an outlook in the era of COVID-19","volume":"202","author":"Videri","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2023.121907_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102595","article-title":"Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19","volume":"117","author":"Valenti","year":"2021","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152136","article-title":"MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19","volume":"226","author":"Speletas","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.lfs.2023.121907_bb1265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb1270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047760","article-title":"The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)","volume":"7","author":"McIntosh","year":"2012","journal-title":"PLoS One"},{"year":"2021","series-title":"The Role of High Cholesterol in Age-related COVID19 Lethality","author":"Wang","key":"10.1016\/j.lfs.2023.121907_bb1275"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s40478-021-01302-7","article-title":"APOE \u03b54 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study","volume":"9","author":"Kurki","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2023.121907_bb1285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2023.121907_bb1290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574508","article-title":"Targeting lipid rafts-a potential therapy for COVID-19","volume":"11","author":"Sviridov","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101938","article-title":"COVID-19 enters the expanding network of apolipoprotein E4-related pathologies","volume":"41","author":"Gkouskou","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.121907_bb1300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","article-title":"Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients","volume":"136","author":"Daniels","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1305","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/qjmed\/hcaa142","article-title":"Does apolipoprotein E genotype predict COVID-19 severity?","volume":"113","author":"Goldstein","year":"2020","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1310","doi-asserted-by":"crossref","first-page":"13483","DOI":"10.1038\/s41598-022-17262-4","article-title":"The association of APOE genotype with COVID-19 disease severity","volume":"12","author":"Safdari Lord","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1315","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/gerona\/glaa200","article-title":"The ApoE locus and COVID-19: are we going where we have been?","volume":"76","author":"Finch","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2023.121907_bb1320","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort","volume":"75","author":"Kuo","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000513182","article-title":"Residence, clinical features, and genetic risk factors associated with symptoms of COVID-19 in a cohort of older people in Madrid","volume":"67","author":"Del Ser","year":"2021","journal-title":"Gerontology"},{"key":"10.1016\/j.lfs.2023.121907_bb1330","article-title":"Pharmacodynamics, network pharmacology, and pharmacokinetics of Chinese medicine formula 9002A in the treatment of Alzheimer\u2019s disease","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1335","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.kint.2020.04.006","article-title":"Collapsing glomerulopathy in a COVID-19 patient","volume":"98","author":"Kissling","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2023.121907_bb1340","first-page":"940","article-title":"Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Vol. 5","volume":"5 (6)","author":"Peleg","year":"2020"},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb1345","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ekir.2020.04.002","article-title":"Collapsing glomerulopathy in a patient with COVID-19","volume":"5","author":"Larsen","year":"2020","journal-title":"Kidney Int. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1350","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1355","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40620-022-01296-y","article-title":"Post-acute COVID-19 syndrome and kidney diseases: what do we know?","volume":"35","author":"Copur","year":"2022","journal-title":"J. Nephrol."},{"issue":"49","key":"10.1016\/j.lfs.2023.121907_bb1360","doi-asserted-by":"crossref","first-page":"24527","DOI":"10.1073\/pnas.1915442116","article-title":"Vitamin D binding protein is required to utilize skin-generated vitamin D","volume":"116","author":"Duchow","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121907_bb1365","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.gene.2018.09.021","article-title":"Vitamin D binding protein polymorphisms influence susceptibility to hepatitis C virus infection in a high-risk Chinese population","volume":"679","author":"Xie","year":"2018","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb1370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126359","article-title":"The DBP phenotype Gc-1f\/Gc-1f is associated with reduced risk of cancer. The Troms\u00f8 Study","volume":"10","author":"Jorde","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1375","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jmv.26409","article-title":"The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate","volume":"93","author":"Karcioglu Batur","year":"2021","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1380","doi-asserted-by":"crossref","first-page":"20837","DOI":"10.1038\/s41598-021-99952-z","article-title":"Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity","volume":"11","author":"Freitas","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1385","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/SHK.0000000000001279","article-title":"Acute lung injury in critically ill patients: actin-scavenger gelsolin signals prolonged respiratory failure","volume":"52","author":"Holm","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2023.121907_bb1390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb1395","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1089\/ars.2012.4640","article-title":"Glutathione-s-transferases as determinants of cell survival and death","volume":"17","author":"Tew","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.lfs.2023.121907_bb1400","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/138920006778017786","article-title":"Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology","volume":"7","author":"Bolt","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.lfs.2023.121907_bb1405","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.747493","article-title":"GSTP1 and GSTM3 variant alleles affect susceptibility and severity of COVID-19","volume":"8","author":"Coric","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb1410","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1002\/jmv.27076","article-title":"Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome","volume":"93","author":"Abbas","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2023.121907_bb1415","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cca.2020.05.041","article-title":"Evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19","volume":"508","author":"Saadat","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1420","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13543776.2017.1254192","article-title":"Role of glutathione-S-transferases in neurological problems","volume":"27","author":"Kumar","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00094-0","article-title":"The morbidity and mortality of COVID-19 are correlated with the Ile105Val glutathione S-transferase P1 polymorphism","volume":"21","author":"Saadat","year":"2020","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb1430","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.121907_bb1435","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.668024","article-title":"The MUC5B promoter polymorphism associates with severe COVID-19 in the European population","volume":"8","author":"van Moorsel","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.lfs.2023.121907_bb1440","article-title":"The possible pathogenesis of idiopathic pulmonary fibrosis considering MUC5B","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1445","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3390\/cimb44080226","article-title":"COVID-19 survivor patients carrying the Rs35705950 risk allele in MUC5B have higher plasma levels of mucin 5B","volume":"44","author":"Garc\u00eda-Carmona","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.lfs.2023.121907_bb1450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103277","article-title":"Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity","volume":"65","author":"Fadista","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2023.121907_bb1455","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.748931","article-title":"Common molecular pathways between post-COVID19 syndrome and lung fibrosis: a scoping review","volume":"13","author":"Bergantini","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121907_bb1460","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fgene.2020.00861","article-title":"Infectivity and progression of COVID-19 based on selected host candidate gene variants","volume":"11","author":"Iyer","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2023.121907_bb1465","first-page":"1","article-title":"Role of CD14 in host protection against infections and in metabolism regulation","volume":"4","author":"Zanoni","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121907_bb1470","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/infdis\/jiab180","article-title":"A CD14 polymorphism (C-159T rs2569190) is associated with SARS-CoV-2 infection and mortality in the european population","volume":"224","author":"Pati","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb1475","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000591","article-title":"Plasma soluble CD14 subtype levels are associated with clinical outcomes in critically ill subjects with coronavirus disease 2019","volume":"3","author":"Mabrey","year":"2021","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.lfs.2023.121907_bb1480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00387","article-title":"The dipeptidyl peptidase family, prolyl oligopeptidase and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis","volume":"6","author":"Waumans","year":"2015","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1485","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3390\/biomedicines10082026","article-title":"Role of dipeptidyl peptidase-4 (DPP4) on COVID-19 physiopathology","volume":"10","author":"Sebasti\u00e1n-Mart\u00edn","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1490","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12041-020-01217-7","article-title":"Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human","volume":"99","author":"Senapati","year":"2020","journal-title":"J. Genet."},{"issue":"276","key":"10.1016\/j.lfs.2023.121907_bb1500","article-title":"Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity","volume":"1","author":"Posadas-s","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1505","first-page":"1","article-title":"C-type lectin CD209L\/L-SIGN and CD209\/DC-SIGN: cell adhesion molecules turned to pathogen recognition receptors","volume":"10","author":"Rahimi","year":"2021","journal-title":"Biology (Basel)"},{"issue":"44","key":"10.1016\/j.lfs.2023.121907_bb1510","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.lfs.2023.121907_bb1515","first-page":"960","article-title":"COVID-19 vaccines: current conditions and future prospects","volume":"10","author":"Zieneldien","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.lfs.2023.121907_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100124","article-title":"COVID-19 vaccines: current evidence and considerations","volume":"12","author":"Tavilani","year":"2021","journal-title":"Metab. Open"},{"issue":"1159","key":"10.1016\/j.lfs.2023.121907_bb1525","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/postgradmedj-2021-140654","article-title":"Review of COVID-19 vaccine subtypes, efficacy and geographical distributions","volume":"98","author":"Francis","year":"2022","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1530","article-title":"The BNT162b2 (BioNTech\/Pfizer) vaccine had 95% efficacy against COVID-19 _7 days after the 2nd dose","volume":"174","author":"Z C","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lfs.2023.121907_bb1535","first-page":"1","article-title":"Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic","volume":"9","author":"Yap","year":"2021","journal-title":"Ther. Adv. Vaccines Immunother."},{"issue":"9","key":"10.1016\/j.lfs.2023.121907_bb1540","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11095-022-03323-w","article-title":"A review on immunological responses to SARS-CoV-2 and various COVID-19 vaccine regimens","volume":"39","author":"Upreti","year":"2022","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.121907_bb1545","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121907_bb1550","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.802312","article-title":"Will host genetics affect the response to SARS-CoV-2 vaccines? Historical precedents","volume":"9","author":"Smatti","year":"2022","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1555","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/hep.29876","article-title":"Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine","volume":"68","author":"Nishida","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1560","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/tan.14546","article-title":"Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine","volume":"99","author":"Crocchiolo","year":"2022","journal-title":"HLA"},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1565","article-title":"HLA-A * 03: 01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination","volume":"3","author":"Bolze","year":"2022","journal-title":"Hum. Genet. Genomics Adv."},{"issue":"3","key":"10.1016\/j.lfs.2023.121907_bb1570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines10030402","article-title":"HLA class II polymorphism and humoral immunity induced by the SARS-CoV-2 mRNA-1273 vaccine","volume":"10","author":"Guti\u00e9rrez-Bautista","year":"2022","journal-title":"Vaccines"},{"issue":"22","key":"10.1016\/j.lfs.2023.121907_bb1575","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.3390\/ijms232214056","article-title":"The CD40-1C>T polymorphism (rs1883832) affects the intensity of IgA antibody responses after BNT162b2 mRNA COVID-19 vaccination","volume":"23","author":"Speletas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121907_bb1580","article-title":"GNB3 c. 825c > T polymorphism in fl uences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine","volume":"13","author":"Ieva","year":"2022","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1585","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/viro.2002.1467","article-title":"Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination","volume":"297","author":"Lindemann","year":"2002","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121907_bb1590","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0014-5793(01)02339-0","article-title":"The G protein \u03b23 subunit 825T allele is a genetic marker for enhanced T cell response","volume":"495","author":"Lindemann","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2023.121907_bb1595","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103153","article-title":"Prophylactic intranasal administration of a TLR2\/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model","volume":"63","author":"Proud","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb1600","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1080\/21645515.2020.1830683","article-title":"SARS-CoV-2 reinfection and implications for vaccine development","volume":"16","author":"Nainu","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1605","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05951","article-title":"Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19","volume":"7","author":"Mustapha","year":"2021","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.lfs.2023.121907_bb1610","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1016\/S2666-7568(21)00253-1","article-title":"Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England","volume":"2","author":"Jeffery-Smith","year":"2021","journal-title":"Lancet Health Longev."},{"key":"10.1016\/j.lfs.2023.121907_bb1615","article-title":"COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: meta-analysis","volume":"1023507","author":"Flacco","year":"2022","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121907_bb1620","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23917","article-title":"Effectiveness associated with vaccination after COVID-19 recovery in preventing reinfection","volume":"5","author":"Lewis","year":"2022","journal-title":"JAMA Netw. Open"},{"year":"2021","series-title":"Interferon Pathway Lupus Risk Alleles Modulate Risk of Death From Acute COVID-19","author":"Nln","key":"10.1016\/j.lfs.2023.121907_bb1625"},{"issue":"1","key":"10.1016\/j.lfs.2023.121907_bb1630","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12967-023-03945-7","article-title":"ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121907_bb1635","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/life13020382","article-title":"Association of the mannose-binding lectin 2 BB genotype with COVID-19-related mortality","volume":"13","author":"Kashiwagi","year":"2023","journal-title":"Life"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:44:59Z","timestamp":1744184699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":327,"alternative-id":["S0024320523005428"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121907","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121907"}}